IL-2/anti-IL-2 antibody complex treatment inhibits the development but not the progression of herpetic stromal keratitis.
IL-2/anti-IL-2 antibody complex treatment inhibits the development but not the progression of herpetic stromal keratitis.
复制标题
DOI:
10.4049/jimmunol.1401285
复制
发表时间:
2015-01-01
期刊:
影响因子:
--
通讯作者:
Suvas S
中科院分区:
文献类型:
--
作者:
Gaddipati S;Estrada K;Rao P;Jerome AD;Suvas S
Interleukin-2 (IL-2) and anti-IL-2 antibody immune complex has recently been shown to expand the naturally occurring pool of CD4+Foxp3+ regulatory T cells (Foxp3+ Tregs). In this report, we showed that administration of IL-2/anti-IL-2 antibody immunocomplex to C57BL/6 mice, prior to corneal herpes simplex virus-1 (HSV-1) infection, significantly increased the pool of Foxp3+ Tregs when measured at early time-points post-infection. Increased numbers of Foxp3+ Tregs on day 2 and day 4 post-infection resulted in a marked reduction in the development of severe HSK. When compared to corneas from the control group, corneas from the immunocomplex-treated group showed a significant reduction in the amount of infectious virus on day 2 but not on day 4 post-infection. Reduced viral load was associated with two-fold increase in NK cell numbers in corneas from the immunocomplex-treated group of mice. Moreover, a dramatic reduction in the influx of CD4 T cells in inflamed corneas was determined on days 7 and 16 post-infection in the immunocomplex-treated group of infected mice. Immunocomplex treatment given on days 5, 6 and 7 post-infection significantly increased Foxp3+ Tregs in draining lymph nodes and in the spleen but failed to reduce the severity of HSK. In terms of the influx of CD4 T cells and granulocytes into inflamed corneas, no significant differences were noted between both groups of mice on day 16 post-infection. Our findings demonstrate that increasing Foxp3+ Tregs early but not late after infection in secondary lymphoid tissues is more efficacious in controlling the severity of HSK.
登录
查看更多内容
DOI:
10.1084/jem.20041033
发表时间:
2005-09-19
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Samy ET;Parker LA;Sharp CP;Tung KS
通讯作者:
Tung KS
影响因子:
5.4
作者:
Reddy, Pradeep B. J.;Schreiber, Taylor H.;Rouse, Barry T.
通讯作者:
Rouse, Barry T.
影响因子:
82.9
作者:
Korn, Thomas;Reddy, Jayagopala;Kuchroo, Vijay K.
通讯作者:
Kuchroo, Vijay K.
影响因子:
3.8
作者:
Keadle, TL;Morris, JL;Stuart, PM
通讯作者:
Stuart, PM
影响因子:
17.8
作者:
Rowe AM;St Leger AJ;Jeon S;Dhaliwal DK;Knickelbein JE;Hendricks RL
通讯作者:
Hendricks RL